April 20, 2024
Bioactive Peptide Market

The Bioactive Peptide Market is gaining prominence through Functionalizing Food & Beverages

The bioactive peptide market comprises peptides derived from food sources that provide specific health benefits beyond basic nutrition. Bioactive peptides are inactive within the parent protein source and can be released through enzymatic hydrolysis during food processing, gastrointestinal digestion, or fermentation by microorganisms. Commonly used bioactive peptides include antihypertensives, antioxidants, immuno-modulatory peptides, and opioid peptides. Bioactive peptides find widespread applications in functionalizing dairy products, drinks, bakery & confectionary, meat & meat products, infant formulas, and clinical nutrition & dietary supplements. They help boost overall health, immunity, cardiovascular health, gut microbiota, and cognitive function.

The Global Bioactive Peptide Market Demand is estimated to be valued at US$ 11.29 Billion in 2024 and is expected to exhibit a CAGR of 8.0% over the forecast period 2024 to 2030.

Bioactive peptides offer advantages over synthetic ingredients as they are natural, non-allergenic and non-toxic. The growing demand for functional and clinically-proven ingredients in foods has boosted the demand for bioactive peptides.

Key Takeaways

Key players operating in the Bioactive Peptide Market are Archer Daniels Midland Company, Seagarden AS, Phermpep Co. Ltd., Arlak Biotech Pvt. Ltd., Naturade, Royal DSM, MYOS RENS Technology Inc., Natural Factors Inc., Valio Oy, GenScript, HELIX BIOMEDIX, Oryn Therapeutics, Selecta Biosciences, NIBEC, vivitide, PEPTIDE INSTITUTE, INC, BCN Peptides, Setlance srl., APEPTICO Forschung und Entwicklung GmbH, and BIONANOPLUS.

The demand for functional foods and beverages containing bioactive peptides is growing worldwide due to increasing health awareness and focus on preventive healthcare. Bioactive peptides help support specific health targets like bone health, digestive health, heart health, skin health, sports nutrition and weight management.

Major bioactive peptide manufacturers are focusing on geographic expansion and capacity enhancements to cater to the growing global demand. They are investing in R&D to develop novel delivery systems and identify new peptide sources. Several clinical studies are being conducted to expand the portfolio of proven health benefits for bioactive peptides.

Market Key Trends

The integration of bioactive peptides in medical nutrition is a key trend. Bioactive peptides are being added to formulas for conditions like sarcopenia, weight management, diabetes, and gastrointestinal disorders due to their demonstrated therapeutic effects. Enzymatic hydrolysis is allowing conventional proteins to be broken down into active peptides with pre-defined sequences. This enhanced technology is helping unlock more bioactive potential from various food sources. Customized peptide mixtures and sequential combinations of peptides are also being explored to develop multi-functional solutions.

Porter’s Analysis
Threat of new entrants: The bioactive peptide market requires high research and development investments as well as expertise in biochemical analysis which acts as a barrier for new companies.

Bargaining power of buyers: Individual consumers have low bargaining power in the global bioactive peptide market due to the highly specialized nature of products however larger institutional buyers may obtain better pricing.

Bargaining power of suppliers: A few major players dominate the upstream supply of raw materials for bioactive peptides such as amino acids which gives them strong bargaining power over buyers.

Threat of new substitutes: There exists a low-to-moderate threat of substitution as novel functional ingredients and proteins with similar health promoting qualities can replace bioactive peptides.

Competitive rivalry: The bioactive peptide market witnesses high competition due to the presence of numerous pharmaceutical and nutraceutical companies offering various patented peptide formulations.

Geographical Regions of Concentration
North America accounts for the largest share of the global bioactive peptide market in terms of value due to rising health consciousness and increasing adoption of nutraceuticals in the region.

Fastest Growing Geographical Region
Asia Pacific region is expected to grow at the fastest rate during the forecast period owing to rising disposable incomes, growing middle class population and their willingness to pay premium prices for health and wellness products.

*Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it